1
Total investments
0
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2018
Minze Health is transforming urology with an at-home diagnostics and digital therapeutics platform designed for scalable, personalized care. With CE marking and 510(k) exemptions, Minze supports early diagnosis and effective management of conditions like benign prostatic hyperplasia (BPH) and overactive bladder (OAB), empowering patients and easing demands on urology systems.
Experience · 3 entries
All (3)
Investments (1)
Board (1)
2019
Chief Executive Officer
Jan 2019
Cbio A/S is a biopharmaceutical company developing next generation T-cell therapies against solid tumors. We are soon to enter our First-in-Human clinical study at Karolinska Hospital in Sweden with our proprietary T-cell product, novoleucel, where the T-cell are armed against oxidative stress.
We are located in Copenhagen, Denmark in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.
2018
Board Member
May 2018
Minze Health is transforming urology with an at-home diagnostics and digital therapeutics platform designed for scalable, personalized care. With CE marking and 510(k) exemptions, Minze supports early diagnosis and effective management of conditions like benign prostatic hyperplasia (BPH) and overactive bladder (OAB), empowering patients and easing demands on urology systems.
1994